Analysis of the role of mifepristone combined with misoprostol in early pregnancy induced abortion in patients with scarred uterus
Objective To study the effect of mifepristone combined with misoprostol on early pregnancy induced abortion in patients with scarred uterus.Methods 41 patients with early pregnancy(5~12 weeks of pregnancy)undergoing miscarriage due to scarred uterus were selected as the study group;Another 41 patients who underwent early miscarriage in non scarred uterus during the same period were selected as the control group.Both groups underwent medical abortion with a combination of mifepristone and misoprostol.Compare the effectiveness and safety of two sets of applications.Results There was no statistically significant difference in the complete abortion rate between the two groups of medication(P>0.05).The incidence of adverse reactions in the study group was 21.95%,while in the control group it was 24.39%.There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).There was no statistically significant difference(P>0.05)in the recovery time of menstruation and the time for blood chorionic gonadotropin(HCG)to return to normal between the two groups.Conclusion The use of mifepristone combined with misoprostol for medical abortion in early pregnancy patients with scarred uterus has good efficacy,safety,and patient prognosis recovery,and is worthy of clinical promotion.